The present study attempts to investigate the effect of adjunctive therapy with metformin and acarbose in patients with Type-1 diabetes mellitus.
Method: In a single-center, placebo-controlled study (IRCT201102165844N1) we compared the results of two clinical trials conducted in two different time periods on 40 patients with Type-1 diabetes mellitus.
Conclusion: The results of this experiment demonstrate that the addition of acarbose or metformin to patients with Type-1 diabetes mellitus who are controlled with insulin is commonly well tolerated and help to improve metabolic control in patients.
These diseases include type-1 diabetes mellitus, celiac disease, multiple sclerosis (MS), and rheumatoid arthritis.
In particular, the ORs for type-1 diabetes mellitus, celiac disease, MS, and rheumatoid arthritis were 2.
Cases: All type-1 diabetes mellitus
patients and all type 2 diabetes mellitus patients of < 40 years of age group (both genders), critically ill persons, and pregnant female subjects were excluded from the study.
Educational program for patients with type-1 diabetes mellitus
receiving free monthly supplies of insulin improves knowledge and attitude, but not adherence; Int J Diabetes Dev Ctries.
Type-1 diabetes mellitus was induced by injecting streptozotocin (STZ) in EDB group.
It was concluded that Type-1 Diabetes Mellitus result in greater orthodontic tooth movement and increased osteoclasts as compared to normal subjects.
The results of present study revealed the effect of type-1 diabetes mellitus in terms of greater magnitude of orthodontic tooth movement and increased osteoclasts count in EDB rats as compared to NG rats on appliance side.
Dr Jamal said there are many type of diabetes but most common are type-1 diabetes mellitus
and type-2 diabetes mellitus.
Cardiac autonomic neuropathy (CAN) in type-1 diabetes mellitus
patients and its association with the duration of disease and glycemic control.